Shopping Cart
- Remove All
Your shopping cart is currently empty
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,870 | 3-6 months | |
| 50 mg | $3,780 | 3-6 months | |
| 100 mg | $5,200 | 3-6 months |
| Description | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
| Molecular Weight | 603.55 |
| Formula | C29H32F2N3O7P |
| Cas No. | 1258595-14-0 |
| Relative Density. | 1.414 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | 1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
1M NaOH
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.